ARGYLE PHARMACY INC
Share on:
| Name: | ARGYLE PHARMACY INC |
| Jurisdiction: | New York |
| Legal type: | DOMESTIC BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 02 Dec 2019 (6 years ago) |
| Entity Number: | 5664388 |
| ZIP code: | 11230 |
| County: | Kings |
| Place of Formation: | New York |
| Address: | 1211 FOSTER AVENUE, BROOKLYN, NY, United States, 11230 |
Contact Details
Phone +1 718-421-0099
Shares Details
Shares issued 200
Share Par Value 0
Type NO PAR VALUE
| Name | Role | Address |
|---|---|---|
| TIMUR YUZEFPOLSKIY | DOS Process Agent | 1211 FOSTER AVENUE, BROOKLYN, NY, United States, 11230 |
| Name | Role | Address |
|---|---|---|
| TIMUR YUZEFPOLSKIY | Chief Executive Officer | 1211 FOSTER AVENUE, BROOKLYN, NY, United States, 11230 |
| Number | Status | Type | Date | End date |
|---|---|---|---|---|
| 2108798-DCA | Active | Business | 2022-09-14 | 2025-03-15 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2025-05-28 | 2025-05-28 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2025-05-28 | 2025-06-03 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2025-05-15 | 2025-05-28 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2025-05-13 | 2025-05-15 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2025-05-12 | 2025-05-13 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 231215002880 | 2023-12-15 | BIENNIAL STATEMENT | 2023-12-15 |
| 220428003475 | 2022-04-28 | BIENNIAL STATEMENT | 2021-12-01 |
| 191202010196 | 2019-12-02 | CERTIFICATE OF INCORPORATION | 2019-12-02 |
| Fee Sequence Id | Fee type | Status | Date | Amount | Description |
|---|---|---|---|---|---|
| 3576934 | RENEWAL | INVOICED | 2023-01-04 | 200 | Dealer in Products for the Disabled License Renewal |
| 3522528 | LICENSE | INVOICED | 2022-09-13 | 100 | Dealer in Products for the Disabled License Fee |
This company hasn't received any reviews.
Date of last update: 23 Mar 2025
Sources: New York Secretary of State